Our Specialists for Acute Ischemic Stroke (Large-Vessel Occlusion)

UChicago Medicine is a Comprehensive Stroke Center with 24/7 endovascular coverage. The cerebrovascular and endovascular neurosurgeons below perform mechanical thrombectomy around the clock and partner with vascular neurology, neurocritical care, and neuroradiology to move eligible patients from door to reperfusion as quickly as possible.

Dr. Doron
Omer Doron, M.D., Ph.D.
Endovascular Neurosurgeon

Dr. Doron is an endovascular neurosurgeon who brought more than 2,500 endovascular procedures with him from his Harvard/MGH fellowship. He performs both catheter-based and open microsurgical treatment of aneurysms, stroke, and vascular malformations, and he is building out thrombectomy capability across UChicago's regional network. He holds a PhD in biomedical engineering from Hebrew University of Jerusalem. Dr. Doron is a dual-trained cerebrovascular and endovascular neurosurgeon whose research on door-in-door-out transfer times for thrombectomy patients shaped how hub-and-spoke stroke networks move patients to reperfusion faster (Interventional Neuroradiology, 2024). At UChicago he performs stent-retriever and aspiration thrombectomy around the clock for anterior and posterior LVO stroke.

JZ
Jehad Zakaria, M.D.
Endovascular Neurosurgeon

Dr. Zakaria is an endovascular neurosurgeon performing catheter-based treatment of stroke, brain aneurysms, and vascular malformations. He practices alongside the department's expanding cerebrovascular program, contributing to the regional thrombectomy and neurovascular service at UChicago. Dr. Zakaria is a cerebrovascular and endovascular neurosurgeon on the UChicago 24/7 stroke call team, performing mechanical thrombectomy for acute large-vessel occlusions and treating the aneurysms, carotid disease, and intracranial stenosis that often sit upstream of them.

Dr. Polster
Sean P. Polster, M.D.
Co-Director, Stroke Center; Safadi Faculty Scholar

Dr. Polster is Co-Director of the Stroke Center and directs the Skull Base & Neurovascular Laboratory at UChicago. He leads the Gut-Brain Axis Laboratory, where he was the first to demonstrate that the gut microbiome modulates the effects of radiosurgery on the neurovascular unit. His work is funded at the NIH NINDS R-level, and he has published in Nature Communications, Blood, Stroke, and the Journal of Neurosurgery. Dr. Polster is a fellowship-trained cerebrovascular neurosurgeon at UChicago whose clinical practice spans aneurysms, AVMs, cavernous malformations, and acute stroke intervention (Journal of Neurosurgery, 2019). He is part of the neuroendovascular team that covers thrombectomy call for Chicago’s South Side Comprehensive Stroke Center.

What Is an Acute Ischemic Stroke from Large-Vessel Occlusion?

A stroke happens when blood flow to part of your brain is suddenly cut off. Without oxygen, brain cells start dying within minutes. About 87% of strokes are ischemic, meaning they are caused by a clot blocking an artery rather than by bleeding. Of those ischemic strokes, roughly one in three involves a large-vessel occlusion (LVO) — a clot stuck in one of the main arteries feeding the brain.

Large-vessel strokes are the most dangerous kind. Because they cut off blood supply to a huge area of brain tissue at once, they are responsible for most stroke-related death and permanent disability. The good news is that they are also the kind of stroke where a modern procedure called mechanical thrombectomy — physically pulling the clot out through a catheter — can make a dramatic difference.

Stroke doctors talk about “time is brain” for a reason: with every minute of an untreated LVO, about 1.9 million neurons die. But they also talk about “tissue is brain”: some patients still have brain cells that are starving but not yet dead even many hours later, and modern imaging can find them. That is why patients who would have been sent home untreated ten years ago are now leaving the hospital walking and talking today.

At a Glance

  • A large-vessel occlusion (LVO) is a stroke caused by a clot blocking one of the big arteries that supply the brain, and it is the kind of stroke most likely to cause major disability
  • Mechanical thrombectomy uses a catheter threaded from the groin or wrist up into the brain artery to physically remove the clot
  • Eligible patients can be treated up to 24 hours from when they were last known well if imaging shows brain tissue that is still salvageable
  • IV clot-busting medication (tPA or tenecteplase) is given first when the patient qualifies; thrombectomy is done in addition, not instead
  • UChicago Medicine is a Comprehensive Stroke Center with a 24/7 neuroendovascular team ready to treat LVO strokes at any hour
Talk to Our Team

Have imaging or a diagnosis already?

We'll have a specialist review your MRI and records — often within 24 hours.

Call (773) 702-2123

What Does It Feel Like?

Stroke symptoms come on suddenly. They usually do not hurt, which is part of what makes them dangerous — people wait to see if it will pass. It will not. The faster you get to a hospital with a stroke team, the better your outcome is going to be.

The BE FAST warning signs

Symptoms that suggest a large-vessel occlusion

LVO strokes tend to cause more severe, combined symptoms because they knock out a big piece of brain at once:

If you see any of these, call 911 immediately. Do not drive yourself. Paramedics can pre-notify the stroke team and route you to a Comprehensive Stroke Center like UChicago Medicine, where thrombectomy is available around the clock.

How Is It Diagnosed?

Everything about stroke diagnosis is built for speed. From the moment you arrive, a clock starts running and a choreographed team — ER, neurology, neurosurgery, radiology, nursing, and pharmacy — moves in parallel rather than in sequence.

Non-contrast CT scan

The first scan rules out bleeding in the brain, because bleeding and clotting strokes look similar on the outside but need opposite treatments. If there is no blood, and your symptoms fit a stroke, you are eligible to be considered for clot-busting medicine.

CT angiogram (CTA)

A quick injection of contrast dye lets us see every major brain artery on the CT scanner. This is where we find the large-vessel occlusion — a clot stuck in the internal carotid artery, the middle cerebral artery (M1 or M2 branches), or the basilar artery at the back of the brain. Finding an LVO is what triggers the thrombectomy pathway.

Perfusion imaging (CTP or MRI)

This is the technology that changed stroke care. Perfusion scans show two things: the core (brain tissue that is already dead) and the penumbra (brain tissue that is starving but still alive and salvageable if we restore blood flow quickly). A small core with a large penumbra — what stroke doctors call a mismatch — is a green light for thrombectomy even 6, 12, or up to 24 hours after symptoms began. Without this imaging, those late-presenting patients would be sent home. With it, many of them walk out of the hospital.

NIH Stroke Scale (NIHSS)

Alongside imaging, the team scores your neurological exam on a 0–42 scale. A score of 6 or higher combined with an LVO on imaging generally meets criteria for thrombectomy.

Types of Large-Vessel Occlusion

Where the clot is lodged determines which part of your brain is at risk and which approach the neuroendovascular team will use to reach it.

Anterior circulation LVO (the front of the brain)

Posterior circulation LVO (the back of the brain and brainstem)

Anterior and posterior LVOs present and behave differently, but the core treatment principle is the same: find the clot fast, open the vessel, and protect whatever brain tissue still has a chance.

How Is It Treated?

IV thrombolysis — alteplase (tPA) or tenecteplase

If you arrive within about 4.5 hours of your last known well time and you do not have a condition that makes bleeding too risky, the stroke team will give you a clot-busting drug through an IV. For decades the standard drug has been alteplase (tPA); many centers, including UChicago, now use tenecteplase, a newer agent that is given as a single fast push and has been shown to work as well or better before thrombectomy. IV thrombolysis does not replace thrombectomy for large-vessel clots — it is a first punch that sometimes helps soften the clot before the catheter goes in.

Mechanical thrombectomy — pulling the clot out

For large-vessel occlusions, thrombectomy is the definitive treatment. Under conscious sedation or light anesthesia, the neuroendovascular surgeon threads a thin catheter from a tiny puncture in the groin (femoral artery) or wrist (radial artery) up through the aorta and into the blocked brain artery. Two tools, usually used together, actually remove the clot:

Most UChicago cases use a combined approach. The goal is TICI 2b or 3 reperfusion — meaning more than half, or ideally all, of the blocked territory has been reopened. Higher TICI scores are directly tied to better patient outcomes.

The extended window — 6 to 24 hours

Until 2018, thrombectomy was only offered in the first 6 hours. Two landmark trials changed that. The DAWN trial showed that patients presenting 6–24 hours after last known well benefit dramatically when perfusion imaging shows a small core and a large penumbra. The DEFUSE-3 trial extended the window to 16 hours using similar mismatch criteria. Together, these two studies mean that wake-up strokes and patients who could not get to the hospital immediately are now routinely treated successfully at UChicago.

After the procedure

Patients recover in a dedicated neurocritical care unit, usually for 24–48 hours. Blood pressure, glucose, and swallowing are managed intensively. The team searches for the cause of the stroke — atrial fibrillation, carotid narrowing, a heart defect — so that the next stroke can be prevented. Most patients then transition to inpatient stroke rehabilitation.

Second Opinion

Considering surgery or planning a second opinion?

Our multidisciplinary team reviews complex cases together. You'll get a coordinated plan, not one opinion.

Call (773) 702-2123

What Are the Outcomes?

Before mechanical thrombectomy existed, about 15–20% of patients with a severe large-vessel stroke could live independently 90 days later. After the 2015 thrombectomy trials — MR CLEAN, ESCAPE, EXTEND-IA, SWIFT PRIME, and REVASCAT — that number roughly doubled. Two things drive a good outcome: how complete the reperfusion is (TICI score) and how fast it happens (time from onset to reopened artery).

FactorIndependent at 90 days (mRS 0–2)What to know
No thrombectomy (medical only)~19%Pooled control arm from HERMES
Thrombectomy, any TICI~46%Pooled thrombectomy arm from HERMES
Thrombectomy, TICI 2b/3 reperfusion~50–60%Substantial reperfusion drives outcome
Thrombectomy, TICI 3 (complete) reperfusion~60–70%Best-case scenario
Extended window 6–24h (DAWN)49% vs 13% medicalMismatch-selected patients
Basilar artery occlusion (ATTENTION)~46% mRS 0–3 vs 23% medicalLife-saving for a once-uniformly-fatal stroke

Every 30 minutes saved from onset to reperfusion adds about a 10% absolute gain in the chance of a good outcome. That is why stroke systems of care, door-to-puncture times, and a 24/7 neuroendovascular team matter as much as the device inside the catheter. UChicago Medicine’s Comprehensive Stroke Center is built around that clock.

References

National Institute of Neurological Disorders and Stroke rt-PA Stroke Study Group. Tissue plasminogen activator for acute ischemic stroke. New England Journal of Medicine. 1995;333(24):1581-1587. PMID: 7477192
Berkhemer OA, Fransen PSS, Beumer D, et al. A randomized trial of intraarterial treatment for acute ischemic stroke (MR CLEAN). New England Journal of Medicine. 2015;372(1):11-20. PMID: 25517348
Goyal M, Demchuk AM, Menon BK, et al. Randomized assessment of rapid endovascular treatment of ischemic stroke (ESCAPE). New England Journal of Medicine. 2015;372(11):1019-1030. PMID: 25671798
Campbell BCV, Mitchell PJ, Kleinig TJ, et al. Endovascular therapy for ischemic stroke with perfusion-imaging selection (EXTEND-IA). New England Journal of Medicine. 2015;372(11):1009-1018. PMID: 25671797
Saver JL, Goyal M, Bonafe A, et al. Stent-retriever thrombectomy after intravenous t-PA vs. t-PA alone in stroke (SWIFT PRIME). New England Journal of Medicine. 2015;372(24):2285-2295. PMID: 25882376
Jovin TG, Chamorro A, Cobo E, et al. Thrombectomy within 8 hours after symptom onset in ischemic stroke (REVASCAT). New England Journal of Medicine. 2015;372(24):2296-2306. PMID: 25882510
Goyal M, Menon BK, van Zwam WH, et al. Endovascular thrombectomy after large-vessel ischaemic stroke: a meta-analysis of individual patient data from five randomised trials (HERMES). The Lancet. 2016;387(10029):1723-1731. PMID: 26898852
Nogueira RG, Jadhav AP, Haussen DC, et al. Thrombectomy 6 to 24 hours after stroke with a mismatch between deficit and infarct (DAWN). New England Journal of Medicine. 2018;378(1):11-21. PMID: 29129157
Albers GW, Marks MP, Kemp S, et al. Thrombectomy for stroke at 6 to 16 hours with selection by perfusion imaging (DEFUSE-3). New England Journal of Medicine. 2018;378(8):708-718. PMID: 29364767
Campbell BCV, Mitchell PJ, Churilov L, et al. Tenecteplase versus alteplase before thrombectomy for ischemic stroke (EXTEND-IA TNK). New England Journal of Medicine. 2018;378(17):1573-1582. PMID: 29694815
Powers WJ, Rabinstein AA, Ackerson T, et al. Guidelines for the early management of patients with acute ischemic stroke: 2019 update to the 2018 guidelines from the American Heart Association/American Stroke Association. Stroke. 2019;50(12):e344-e418. PMID: 31662037
Tao C, Nogueira RG, Zhu Y, et al. Trial of endovascular treatment of acute basilar-artery occlusion (ATTENTION). New England Journal of Medicine. 2022;387(15):1361-1372. PMID: 36239644
Ahmed RA, Withers JR, McIntyre JA, et al. Impact and determinants of door in-door out time for stroke thrombectomy transfers in a large hub-and-spoke network. Interventional Neuroradiology. 2024;online ahead of print. PMID: 38872477

Have Questions About Stroke Care?

Our team is here to review your case, discuss your options, and help you take the next step.

Schedule: (773) 702-2123